Improving Heart Function

⏳ This Friday: Don’t miss our iHF webinar on HFrEF and CCS

Join us for a live discussion dedicated to one of the most challenging areas in contemporary cardiovascular care: the management of patients with HFrEF and CCS.

📅 19 June 2026 | 17:30 - 18:30 (UTC+2)

👉 Register online now: https://brnw.ch/21x3rqC

Expert panel: Martine Gilard, Sabine Bleiziffer, Marta Belmonte, Emiliano Fiori, Ahmed Bennis and Amina Rakisheva.

🫀 How do we optimise care pathways for patients with HFrEF and chronic coronary syndromes in contemporary practice?

📆 Next iHF Webinar: Friday 19 June 2026 at 5:30pm (UTC+2)

Join leading international experts for an in-depth discussion on:
- Guideline-directed medical therapy)
- Revascularisation strategies in HFrEF
- Patient selection and multidisciplinary decision-making
- Post-revascularisation optimisation and long-term management

Speakers: Nadya Al Matrooshi, Emiliano Fiori, Sabine Bleiziffer, ahmed BENNIS, Amina Rakisheva and Martine Gilard

🔗 Register for free now: https://www.iheartfunction.com/webinars/hfref-and-chronic-coronary-syndromes-guided-directed-medical-therapy-optimal

𝗶𝗛𝗙 𝗮𝘁 2026 !

We are pleased to invite you to a dedicated session "When to best combine guided-directed medical therapy and devices at discharge of acute heart failure" at EuroPCR 2026.

📅 Wednesday 20 May I 9:45 - 10:45
📍 Room 243

Together with Alexandre Mebazaa, Pascal Vranckx and our discussants, the session will explore GDMT, cardiac resynchronisation therapy, and the benefits of combining both GDMT and devices at discharge of acute heart failure.

Hope to see many of you there!

Learn more: https://brnw.ch/21x2wgf

🎥 Session replay now available – 2026

Patients with aortic stenosis and HFrEF present unique therapeutic challenges. How should clinicians integrate guideline-directed medical therapy and percutaneous valve interventions to improve outcomes?

In this iHF Course session, leading experts explore practical strategies through a multidisciplinary discussion.

🔎 Topics include:
• Optimising medical therapy in HFrEF with concomitant valve disease
• Identifying candidates for TAVI or other percutaneous strategies
• Building a Heart Team approach for complex HF patients

Faculty: Marta Belmonte I Andrew Coats I Raul Moreno I Pasquale Paolisso I Sergio Raposeiras-Roubin I Ester Perez-David I Izabelle Uchmanowicz I Byungsu Yoo

Integrated care in aortic stenosis and HFrEF: from medical therapy to percutaneous intervention This session of the IHF course 2026 focuses on the integrated care of patients with aortic stenosis and heart failure with reduced ejection fraction (HFrEF), emphasizing the transition from medical therapy to percutaneous interventions like TAVI. 

🎥 2026 - New session replay online!

complicated by cardiogenic shock: why a trans-disciplinary approach is essential
In this iHF Course session, the multidisciplinary panel of experts discusses why improving outcomes requires more than individual expertise.
🔑 Key insights:
- Early recognition of cardiogenic shock is crucial
- Rapid risk stratification helps guide treatment decisions
- Management often requires , intensive care and mechanical circulatory support
- A coordinated trans-disciplinary shock team approach improves patient outcomes

This model ensures faster decisions, better coordination between specialties and improved patient safety in high-risk ACS cases.

Expert panels: Alexandre Mebazaa I Hatem Soliman I Offer Amir I Owais Dar I Marina Clement I Antoine Kimmoun I Salvatore Brugaletta

ACS with cardiogenic shock: challenging clinical settings in need of trans-disciplinary management Master VSD-related cardiogenic shock management. Explore SCAI stages, hemodynamic phenotyping, and the optimal timing for MCS and surgical repair.